Ichikawa D, Yamaguchi T, Yoshioka Y, Sawai K, Takahashi T
First Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
Am J Surg. 1996 Mar;171(3):346-50. doi: 10.1016/S0002-9610(97)89639-0.
Since 1977, we have studied preoperative treatments using 5-fluorouracil (5-FU) suppositories alone or in combination with radiation to reduce local recurrence and improve survival of patients with rectal cancer.
We developed a novel preoperative therapy combining radiation, intraluminal hyperthermia, and 5-FU suppositories. Thirty-five patients with rectal cancer underwent surgery after this treatment, and 41 patients underwent surgery without pretreatment.
The patients who underwent preoperative combination treatment showed significant tumor reduction; 2 achieved microscopically complete regression. In comparison with the patients who underwent surgery without pretreatment, the preoperative treatment group had a 16.7% lower local recurrence rate (10.4% versus 27.1%) and an improved survival rate (81.8% versus 67.6%).
Preoperative combination therapy is a promising modality for the patients with respectable advanced cancer in the lower rectum.
自1977年以来,我们研究了单独使用5-氟尿嘧啶(5-FU)栓剂或联合放疗进行术前治疗,以降低直肠癌患者的局部复发率并提高生存率。
我们开发了一种将放疗、腔内热疗和5-FU栓剂相结合的新型术前治疗方法。35例直肠癌患者接受该治疗后进行了手术,41例患者未接受预处理直接进行了手术。
接受术前联合治疗的患者肿瘤明显缩小;2例达到显微镜下完全缓解。与未接受预处理而直接手术的患者相比,术前治疗组的局部复发率低16.7%(10.4%对27.1%),生存率有所提高(81.8%对67.6%)。
术前联合治疗对于下段直肠可切除的进展期癌症患者是一种有前景的治疗方式。